Publicaciones (60) Publicaciones de Jesús García Mata

2022

  1. Emesis y quimioterapia. Más allá de los setrones y los antagonistas del receptor NK1

    Revisiones en Cancer, Vol. 36, Núm. 2, pp. 104-112

  2. Establishing an Expert Consensus on Key Indicators of the Quality of Life among Breast Cancer Survivors: A Modified Delphi Study

    Journal of Clinical Medicine, Vol. 11, Núm. 7

2021

  1. Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group

    Journal of Geriatric Oncology, Vol. 12, Núm. 3, pp. 410-415

  2. Electronic health records and patient registries in medical oncology departments in Spain

    Clinical and Translational Oncology, Vol. 23, Núm. 10, pp. 2099-2108

  3. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

    Annals of Oncology, Vol. 32, Núm. 10, pp. 1245-1255

  4. Patients-centered SurvivorShIp care plan after Cancer treatments based on Big Data and Artificial Intelligence technologies (PERSIST): a multicenter study protocol to evaluate efficacy of digital tools supporting cancer survivors

    BMC Medical Informatics and Decision Making, Vol. 21, Núm. 1

2020

  1. Maintenance treatment in metastatic colorectal cancer: in search of the best strategy

    Clinical and Translational Oncology, Vol. 22, Núm. 8, pp. 1205-1215

  2. Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report

    Case Reports in Oncology, Vol. 13, Núm. 1, pp. 69-75

  3. The economic burden of metastatic breast cancer in Spain

    European Journal of Hospital Pharmacy , Vol. 27, Núm. 1, pp. 19-24

2019

  1. Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report

    Frontiers in Oncology, Vol. 9

  2. Primary malignant melanoma of the biliary tract: A case report and literature review

    World Journal of Clinical Cases, Vol. 7, Núm. 16, pp. 2302-2308

  3. Tratamiento perioperatorio en cáncer de vejiga: Revisión de la literatura

    Revisiones en Cancer, Vol. 33, Núm. 5, pp. 210-215

2018

  1. A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain

    Clinical and Translational Oncology, Vol. 20, Núm. 8, pp. 1061-1071

  2. Epidemiología y factores pronósticos de los tumores neuroendocrinos

    Revisiones en Cancer, Vol. 32, Núm. 5, pp. 287-293

  3. Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis—Prognostic and Predictive Factors

    Molecular Diagnosis and Therapy, Vol. 22, Núm. 2, pp. 169-177

  4. Real world data of nivolumab for previously treated non-small cell lung cancer patients: A Galician lung cancer group clinical experience

    Translational Lung Cancer Research, Vol. 7, Núm. 3, pp. 404-415

2016

  1. Ki-67 is a prognostic marker for hormone receptor positive tumors

    Clinical and Translational Oncology, Vol. 18, Núm. 10, pp. 996-1002

2014

  1. Breast cancer management in the elderly

    Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 351-361

2013

  1. SEOM guide to antiemetic prophylaxis in cancer patients treated with chemotherapy 2013

    Clinical and Translational Oncology, Vol. 15, Núm. 12, pp. 1030-1036

2012

  1. Functions and workload of medical oncologists in Spain

    Clinical and Translational Oncology, Vol. 14, Núm. 6, pp. 423-429